Catheter Introducer
FDA Clearance Information
The catheter introducer by Galt Medical was cleared through the FDA 510(k) pathway on February 9, 2005. It is classified as a Class 2 device under product code DYB.
What It Is
FDA-Cleared Indications
- Used to facilitate the introduction and placement of catheters during medical procedures.
- Intended to provide a pathway for catheter access while helping limit tissue trauma during insertion.
Clinical Applications
- Establishing access for catheter-based vascular procedures.
- Facilitating catheter placement during interventional radiology procedures.
- Providing access for procedures in which a catheter must be advanced through a blood vessel or other body passage.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- Introducers are available in different sizes and configurations; the selected size must match the catheter, guidewire, and target access site.
- Use requires sterile technique and imaging or other appropriate guidance when entering a blood vessel or deep body structure.
- Compatibility with the catheter, guidewire, connector, and any hemostasis valve should be confirmed before use.
- MRI safety depends on the specific introducer materials and whether the device remains in the patient; consult the product labeling and institutional MRI policy.
- Potential complications include bleeding, hematoma, infection, vessel injury, thrombosis, air embolism, and damage to the catheter or introducer.
Procedures that use this device
Frequently Asked Questions
What are the clinical indications for catheter introducer?
The catheter introducer is indicated for use in procedures requiring catheter placement, such as vascular access, epidural anesthesia, and urethral catheterization.
What outcomes have been reported in clinical studies?
Studies report reduced nasal trauma in pediatric surgeries and improved catheter placement in epidural anesthesia and urethral catheterization.
What complications have been reported?
Reported complications include potential reduction in nasal trauma and improved aseptic techniques, but specific adverse events are not detailed.